Reviews in
Neuro-Oncology


Volume 21 Number 7
July 2019


Home > Disciplines > Publications > Reviews in Neuro-Oncology > Volume 21, Year 2019 > Number 7, July



CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE MIDLINE GLIOMAS
HIGH-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA





CENTRAL NERVOUS SYSTEM TUMORS

.

Nauclér CS, Geisler J, Vetvik K.
The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications.
Oncotarget. 2019 Jul 2;10(42):4333-4347. doi: 10.18632/oncotarget.27016. eCollection 2019 Jul 2.
Source | Full text | Similar articles



.

Ostrom QT, Adel Fahmideh M, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, Bondy ML.
Risk Factors For Childhood And Adult Primary Brain Tumors.
Neuro Oncol. 2019 Jul 12. pii: noz123. doi: 10.1093/neuonc/noz123. [Epub ahead of print]
Source | Full text | Similar articles



GLIOMAS



DIFFUSE MIDLINE GLIOMAS


.

Gallitto M, Lazarev S, Wasserman I, Stafford JM, Wolden SL, Terezakis SA, Bindra RS, Bakst RL.
Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review.
Adv Radiat Oncol. 2019 Mar 30;4(3):520-531. doi: 10.1016/j.adro.2019.03.009. eCollection 2019 Jul-Sep.
Source | Full text | Similar articles



.

Vitanza NA, Monje M.
Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.
Curr Treat Options Neurol. 2019 Jul 10;21(8):37. doi: 10.1007/s11940-019-0577-y.
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS


.

Hu YJ, Zhang LF, Ding C, Chen D, Chen J.
Hypofractionated stereotactic radiotherapy combined with chemotherapy or not in the management of recurrent malignant gliomas: A systematic review and meta-analysis.
Clin Neurol Neurosurg. 2019 Aug;183:105401. doi: 10.1016/j.clineuro.2019.105401. Epub 2019 Jun 25.
Source | Full text | Similar articles



.

Mormile R.
Aspirin Use and Risk of Glioma: a Double Track for a Single Goal?
Pathol Oncol Res. 2019 Jul 22. doi: 10.1007/s12253-019-00699-w. [Epub ahead of print]
Source | Full text | Similar articles



.

Straube C, Kessel KA, Zimmer C, Schmidt-Graf F, Schlegel J, Gempt J, Meyer B, Combs SE.
A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers.
Curr Treat Options Oncol. 2019 Jul 19;20(9):71. doi: 10.1007/s11864-019-0673-y.
Source | Full text | Similar articles



.

Youssef GC, Gomez-Manzano C, Sawaya R, Fueyo J.
Antitumor immune response during glioma virotherapy.
Neuro Oncol. 2019 Jul 26. pii: noz114. doi: 10.1093/neuonc/noz114. [Epub ahead of print]
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS

.

Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Jun 24.
Source | Book | Similar articles




Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Jun 19.
Source | Book | Similar articles



.

Ritchey AK et al, PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Jul 3.
Source | Book | Similar articles



GLIOBLASTOMA


.

Bailly C, Vidal A, Bonnemaire C, Kraeber-Bodéré F, Chérel M, Pallardy A, Rousseau C, Garcion E, Lacoeuille F, Hindré F, Valable S, Bernaudin M, Bodet-Milin C, Bourgeois M.
Potential for Nuclear Medicine Therapy for Glioblastoma Treatment.
Front Pharmacol. 2019 Jul 10;10:772. doi: 10.3389/fphar.2019.00772. eCollection 2019.
Source | Full text | Similar articles



.

Çetin A, Biltekin B.
Ellagic Acid Enhances Antitumor Efficacy of Temozolomide in an in vitro Glioblastoma Model.
Turk Neurosurg. 2019 May 17. doi: 10.5137/1019-5149.JTN.26026-19.1. [Epub ahead of print]
Source | Full text | Similar articles



.

Desai K, Hubben A, Ahluwalia M.
The Role of Checkpoint Inhibitors in Glioblastoma.
Target Oncol. 2019 Aug;14(4):375-394. doi: 10.1007/s11523-019-00655-3.
Source | Full text | Similar articles



.

Fan X, Xiong Y, Wang Y.
A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications.
Front Med. 2019 Jul 16. doi: 10.1007/s11684-019-0700-1. [Epub ahead of print]
Source | Full text | Similar articles



.

Jackson CM, Choi J, Lim M.
Mechanisms of immunotherapy resistance: lessons from glioblastoma.
Nat Immunol. 2019 Jul 29. doi: 10.1038/s41590-019-0433-y. [Epub ahead of print]
Source | Full text | Similar articles



.

Sander C, Reuschel V, Eisenlöffel C, Nestler U, Meixensberger J.
Familial glioblastoma clustering in adult patients: a case report of two non-twin siblings and review of the literature.
Int Med Case Rep J. 2019 Jul 5;12:205-211. doi: 10.2147/IMCRJ.S201488. eCollection 2019.
Source | Full text | Similar articles



.

Weller M, Le Rhun E, Preusser M, Tonn JC, Roth P.
How we treat glioblastoma.
ESMO Open. 2019 Jun 17;4(Suppl 2):e000520. doi: 10.1136/esmoopen-2019-000520. eCollection 2019.
Source | Full text | Similar articles



bottom